Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SCCOR in Host Factors in Chronic Lung Diseases: Mechanisms of Immune Tolerance and Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA) in Patients With Cystic Fibrosis

NCT00585364 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00585364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00585364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SCCOR in Host Factors in Chronic Lung Diseases: Mechanisms of Immune Tolerance and Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA) in Patients With Cystic Fibrosis
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Completed
Start date
March 31, 2005
Completion date
December 31, 2010
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic bronchopulmonary aspergillosis, cystic fibrosis